1
|
Brindahdevi K, Kim PT, Vignesh Kumar M, Govindasamy C, Anderson A, Gavurová B. Enhancing emission control and analyzing the performance and combustion attributes of vehicular engines with spirulina microalgae diesel Ce 2O 3 nanoparticles blends. Environ Res 2023; 239:117370. [PMID: 37827374 DOI: 10.1016/j.envres.2023.117370] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/03/2023] [Revised: 10/05/2023] [Accepted: 10/09/2023] [Indexed: 10/14/2023]
Abstract
The current research investigates the utilization of spirulina microalgae biodiesel blends in a naturally aspirated constant speed compression ignition engine with Ce2O3 nanoparticles at the concentration of 50 ppm under diverse engine loading conditions. Blends of microalgae dispersed with neat diesel at the volume of 20% and 40%. A series of tests were conducted to evaluate the combined effects of microalgae and nanoparticles on engine performance, combustion efficiency, and emission characteristics. The study revealed that increasing the microalgae concentration in the diesel fuel resulted in reduced brake thermal efficiency due to less effective atomization and lower calorific value. Surprisingly, the 20% biodiesel blend with nanoparticles exhibited the highest brake thermal efficiency across various engine loads, while the 40% blend showed higher brake specific fuel consumption compared to both the 20% blend and neat diesel, primarily because of its lower heating value necessitating increased fuel consumption. Furthermore, the biodiesel blends led to lower in-cylinder pressure than pure diesel, mainly attributable to suboptimal atomization. In terms of emissions, the utilization of microalgae-based fuel led to a significant reduction in NOx, CO, and smoke emissions, attributed to the lower cylinder temperatures associated with these blends. In conclusion, this study underscores the potential of spirulina microalgae, particularly when combined with nanoparticles at an optimal concentration, as a promising and environmentally friendly alternative for compression ignition engines.
Collapse
Affiliation(s)
- Kathirvel Brindahdevi
- Institute of Research and Development, Duy Tan University, Da Nang, Viet Nam; School of Engineering & Technology, Duy Tan University, Da Nang, Viet Nam.
| | - P T Kim
- Institute of Research and Development, Duy Tan University, Da Nang, Viet Nam; School of Engineering & Technology, Duy Tan University, Da Nang, Viet Nam
| | - M Vignesh Kumar
- Department of Aerospace Engineering, SRM Institute of Science and Technology, India.
| | - Chandramohan Govindasamy
- Department of Community Health Sciences, College of Applied Medical Sciences, King Saud University, P.O. Box 10219, Riyadh 11433, Saudi Arabia
| | - A Anderson
- Department of Aeronautical Engineering, Sathyabama Institute of Science and Technology, India
| | - Beata Gavurová
- Technical University of Kosice, Faculty of Mining, Ecology, Process Control and Geotechnologies, Letna 9, Košice, 042 00, Slovakia
| |
Collapse
|
2
|
Khatri AM, Natori Y, Anderson A, Jabr R, Shah SA, Natori A, Chandhok NS, Komanduri K, Morris MI, Camargo JF, Raja M. Breakthrough invasive fungal infections on isavuconazole prophylaxis in hematologic malignancy & hematopoietic stem cell transplant patients. Transpl Infect Dis 2023; 25 Suppl 1:e14162. [PMID: 37794708 DOI: 10.1111/tid.14162] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2023] [Revised: 09/08/2023] [Accepted: 09/19/2023] [Indexed: 10/06/2023]
Abstract
BACKGROUND Isavuconazole (ISA) is a newer antifungal used in patients with history of hematologic malignancies and hematopoietic transplant and cellular therapies (HM/TCT). Although it has a more favorable side-effect profile, breakthrough invasive fungal infections (bIFIs) while on ISA have been reported. METHODS In this single-center retrospective study evaluating HM/TCT patients who received prophylactic ISA for ≥7 days, we evaluated the incidence and potential risk factors for bIFIs. RESULTS We evaluated 106 patients who received prophylactic ISA. The patients were predominantly male (60.4%) with median age of 65 (range: 21-91) years. Acute myeloid leukemia (48/106, 45.3%) was the most common HM, with majority having relapsed and/or refractory disease (43/106, 40.6%) or receiving ongoing therapy (38/106, 35.8%). Nineteen patients (17.9%) developed bIFIs-nine proven [Fusarium (3), Candida (2), Mucorales plus Aspergillus (2), Mucorales (1), Colletotrichum (1)], four probable invasive pulmonary Aspergillus, and six possible infections. Twelve patients were neutropenic for a median of 28 (8-253) days prior to bIFI diagnosis. ISA levels checked within 7 days of bIFI diagnosis (median: 3.65 μg/mL) were comparable to industry-sponsored clinical trials. All-cause mortality among the bIFI cases was 47.4% (9/19).We also noted clinically significant cytomegalovirus co-infection in 5.3% (1/19). On univariate analysis, there were no significant differences in baseline comorbidities and potential risk factors between the two groups. CONCLUSION ISA prophylaxis was associated with a significant cumulative incidence of bIFIs. Despite the appealing side-effect and drug-interaction profile of ISA, clinicians must be vigilant about the potential risk for bIFIs.
Collapse
Affiliation(s)
- Akshay M Khatri
- Division of Infectious Diseases, Department of Medicine, UnityPoint Health-Des Moines, Des Moines, USA
| | - Yoichiro Natori
- Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, USA
- Miami Transplant Institute, Jackson Health System, Miami, USA
| | - Anthony Anderson
- Department of Pharmacy, Sylvester Comprehensive Cancer Center, Miami, USA
| | - Ra'ed Jabr
- Department of Medicine, Division of Infectious Diseases, Mayo Clinic Health System-Eau Claire, Miami, USA
| | - Shreya A Shah
- Department of Pharmacy, Sylvester Comprehensive Cancer Center, Miami, USA
| | - Akina Natori
- Division of Medical Oncology, Department of Medicine, University of Miami Miller School of Medicine, Miami, USA
| | - Namrata S Chandhok
- Division of Hematology, Department of Medicine, University of Miami Miller School of Medicine, Miami, USA
| | - Krishna Komanduri
- Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, USA
| | - Michele I Morris
- Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, USA
| | - Jose F Camargo
- Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, USA
| | - Mohammed Raja
- Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, USA
| |
Collapse
|
3
|
Prasanna C, Realmuto J, Anderson A, Rombokas E, Klute G. A Data-Driven and Personalized Stance Symmetry Controller for Robotic Ankle-Foot Prostheses: A Preliminary Investigation. IEEE Trans Neural Syst Rehabil Eng 2023; 31:4051-4062. [PMID: 37831558 DOI: 10.1109/tnsre.2023.3322124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2023]
Abstract
People with unilateral transtibial amputation generally exhibit asymmetric gait, likely due to inadequate prosthetic ankle function. This results in compensatory behavior, leading to long-term musculoskeletal impairments (e.g., osteoarthritis in the joints of the intact limb). Powered prostheses can better emulate biological ankles, however, control methods are over-reliant on non-disabled data, require extensive amounts of tuning by experts, and cannot adapt to each user's unique gait patterns. This work directly addresses all these limitations with a personalized and data-driven control strategy. Our controller uses a virtual setpoint trajectory within an impedance-inspired formula to adjust the dynamics of the robotic ankle-foot prosthesis as a function of stance phase. A single sensor measuring thigh motion is used to estimate the gait phase in real time. The virtual setpoint trajectory is modified via a data-driven iterative learning strategy aimed at optimizing ankle angle symmetry. The controller was experimentally evaluated on two people with transtibial amputation. The control scheme successfully increased ankle angle symmetry about the two limbs by 24.4% when compared to the passive condition. In addition, the symmetry controller significantly increased peak prosthetic ankle power output at push-off by 0.52 W/kg and significantly reduced biomechanical risk factors associated with osteoarthritis (i.e., knee and hip abduction moments) in the intact limb. This research demonstrates the benefits of personalized and data-driven symmetry controllers for robotic ankle-foot prostheses.
Collapse
|
4
|
Prasanna C, Realmuto J, Anderson A, Rombokas E, Klute G. Using Deep Learning Models to Predict Prosthetic Ankle Torque. Sensors (Basel) 2023; 23:7712. [PMID: 37765769 PMCID: PMC10535406 DOI: 10.3390/s23187712] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/12/2023] [Revised: 08/31/2023] [Accepted: 09/01/2023] [Indexed: 09/29/2023]
Abstract
Inverse dynamics from motion capture is the most common technique for acquiring biomechanical kinetic data. However, this method is time-intensive, limited to a gait laboratory setting, and requires a large array of reflective markers to be attached to the body. A practical alternative must be developed to provide biomechanical information to high-bandwidth prosthesis control systems to enable predictive controllers. In this study, we applied deep learning to build dynamical system models capable of accurately estimating and predicting prosthetic ankle torque from inverse dynamics using only six input signals. We performed a hyperparameter optimization protocol that automatically selected the model architectures and learning parameters that resulted in the most accurate predictions. We show that the trained deep neural networks predict ankle torques one sample into the future with an average RMSE of 0.04 ± 0.02 Nm/kg, corresponding to 2.9 ± 1.6% of the ankle torque's dynamic range. Comparatively, a manually derived analytical regression model predicted ankle torques with a RMSE of 0.35 ± 0.53 Nm/kg, corresponding to 26.6 ± 40.9% of the ankle torque's dynamic range. In addition, the deep neural networks predicted ankle torque values half a gait cycle into the future with an average decrease in performance of 1.7% of the ankle torque's dynamic range when compared to the one-sample-ahead prediction. This application of deep learning provides an avenue towards the development of predictive control systems for powered limbs aimed at optimizing prosthetic ankle torque.
Collapse
Affiliation(s)
- Christopher Prasanna
- Center for Limb Loss and Mobility, Seattle, WA 98108, USA; (C.P.); (A.A.)
- Department of Mechanical Engineering, University of Washington, Seattle, WA 98195, USA;
| | - Jonathan Realmuto
- Bionic Systems Lab, University of California, Riverside, CA 92521, USA;
| | - Anthony Anderson
- Center for Limb Loss and Mobility, Seattle, WA 98108, USA; (C.P.); (A.A.)
- Department of Mechanical Engineering, University of Washington, Seattle, WA 98195, USA;
| | - Eric Rombokas
- Department of Mechanical Engineering, University of Washington, Seattle, WA 98195, USA;
- Department of Electrical and Computer Engineering, University of Washington, Seattle, WA 98195, USA
| | - Glenn Klute
- Center for Limb Loss and Mobility, Seattle, WA 98108, USA; (C.P.); (A.A.)
- Department of Mechanical Engineering, University of Washington, Seattle, WA 98195, USA;
| |
Collapse
|
5
|
Dacres H, Weihs F, Wang J, Anderson A, Trowell SC. Bioluminescence resonance energy transfer biosensor for measuring activity of a protease secreted by Pseudomonas fluorescens growing in milk. Anal Chim Acta 2023; 1270:341401. [PMID: 37311608 DOI: 10.1016/j.aca.2023.341401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2022] [Revised: 05/18/2023] [Accepted: 05/20/2023] [Indexed: 06/15/2023]
Abstract
Bacterial proteases are sporadic contributors to milk spoilage, reducing the quality of ultra-heat treated (UHT) milk and other dairy products. Current methods for measuring bacterial protease activity in milk are insensitive and too slow to be used in routine testing in dairy processing plants. We have designed a novel bioluminescence resonance energy transfer (BRET)-based biosensor to measure the activity of proteases secreted by bacteria in milk. The BRET-based biosensor is highly selective for bacterial protease activity compared with other proteases tested, notably including plasmin, which is abundant in milk. It incorporates a novel peptide linker that is selectively cleaved by P. fluorescens AprX proteases. The peptide linker is flanked by green fluorescent protein (GFP2) at the N-terminus and a variant Renilla luciferase (RLuc2) at the C-terminus. Complete cleavage of the linker by bacterial proteases from Pseudomonas fluorescens strain 65, leads to a 95% decrease in the BRET ratio. We applied an azocasein-based calibration method to the AprX biosensor using standard international enzyme activity units. In a 10-min assay, the detection limit for AprX protease activity in buffer was equivalent to 40 pg/mL (≈0.8 pM, 22 μU/mL) and 100 pg/mL (≈2pM, 54 μU/mL) in 50% (v/v) full fat milk. The EC50 values were 1.1 ± 0.3 ng/mL (87 μU/mL) and 6.8 ± 0.2 ng/mL (540 μU/mL), respectively. The biosensor was approximately 800x more sensitive than the established FITC-Casein method in a 2-h assay, the shortest feasible time for the latter method. The protease biosensor is sensitive and fast enough to be used in production settings. It is suitable for measuring bacterial protease activity in raw and processed milk, to inform efforts to mitigate the effects of heat-stable bacterial proteases and maximise the shelf-life of dairy products.
Collapse
Affiliation(s)
- H Dacres
- CSIRO Health & Biosecurity, Food Innovation Centre, 671 Sneydes Road, Werribee, VIC, 3030, Australia
| | - F Weihs
- PPB Technology Pty Ltd, PO Box 265, Erindale Centre, ACT, 2903, Australia; CSIRO Health & Biosecurity, Canberra, ACT, 2601, Australia.
| | - J Wang
- CSIRO Health & Biosecurity, Canberra, ACT, 2601, Australia
| | - A Anderson
- CSIRO Health & Biosecurity, Canberra, ACT, 2601, Australia
| | - S C Trowell
- PPB Technology Pty Ltd, PO Box 265, Erindale Centre, ACT, 2903, Australia; CSIRO Health & Biosecurity, Canberra, ACT, 2601, Australia
| |
Collapse
|
6
|
Lu H, Xie R, S Almoallim H, Alharbi SA, Jhanani GK, Praveenkumar TR, Anderson A, Xia C. Utilization of the Nannochloropsis microalgae biochar prepared via microwave assisted pyrolysis on the mixed biomass fuel pellets. Environ Res 2023; 231:116078. [PMID: 37182832 DOI: 10.1016/j.envres.2023.116078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/22/2023] [Revised: 05/03/2023] [Accepted: 05/05/2023] [Indexed: 05/16/2023]
Abstract
Nannochloropsis microalgae biochar has become increasingly attractive due to its potential as a component of microalgae-based biodiesel blends. This biochar is a by-product of the pyrolysis process, but its use in the energy sector has been limited. In this study, pellets were formed using microalgae residues and their physiochemical properties were analyzed to assess the feasibility of using microalgae biochar as a fuel source. Three types of biomasses, namely date seed dust, coconut shell waste, and microalgae biochar, were utilized to produce fuel pellets. These pellets were categorized into three types, B1, B2, and B3, based on the composition of the biomass. The inclusion of microalgae biochar in the pellets resulted in enhanced calorific value, as well as improved heating value and bulk density. Moreover, the mechanical strength of microalgae-based pellets was higher due to their high lignin content compared to another biomass. The moisture absorption test results showed that the use of mixed biomass reduced the moisture content over an extended period. Microalgae pellets exhibited higher young's modulus and greater impact resistance, indicating greater mechanical strength. Furthermore, due to their higher calorific value, the combustion time of microalgae pellets was greater than that of other biomass. In conclusion, the results of this study suggest that microalgae biochar can be a promising alternative fuel source for the energy sector.
Collapse
Affiliation(s)
- Haiying Lu
- College of Biology and the Environment, Co-Innovation Center for the Sustainable Forestry in Southern China, Nanjing Forestry University, Nanjing, Jiangsu, 210037, China
| | - Ruiyan Xie
- College of Biology and the Environment, Co-Innovation Center for the Sustainable Forestry in Southern China, Nanjing Forestry University, Nanjing, Jiangsu, 210037, China
| | - Hesham S Almoallim
- Department of Oral and Maxillofacial Surgery, College of Dentistry, King Saud University, PO Box-60169, Riyadh, 11545, Saudi Arabia
| | - Sulaiman Ali Alharbi
- Department of Botany and Microbiology, College of Science, King Saud University, PO Box -2455, Riyadh, 11451, Saudi Arabia
| | - G K Jhanani
- University Centre for Research & Development, Chandigarh University, Mohali, 140103, India
| | - T R Praveenkumar
- Department of Construction Technology and Management, College of Engineering and Technology, Wollega University, Ethiopia.
| | - A Anderson
- Department of Aeronautical Engineering, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India
| | - Changlei Xia
- Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, International Innovation Center for Forest Chemicals and Materials, College of Materials Science and Engineering, Nanjing Forestry University, Nanjing, Jiangsu, 210037, China.
| |
Collapse
|
7
|
Robertson DJ, Shephard MP, Anderson A, Huhe N, Rapp DN, Madsen JK. Editorial: The psychology of fake news on social media, who falls for it, who shares it, why, and can we help users detect it? Front Psychol 2023; 14:1236748. [PMID: 37546452 PMCID: PMC10400351 DOI: 10.3389/fpsyg.2023.1236748] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2023] [Accepted: 06/12/2023] [Indexed: 08/08/2023] Open
Affiliation(s)
- David J. Robertson
- School of Psychological Sciences and Health, University of Strathclyde, Glasgow, United Kingdom
| | - Mark P. Shephard
- School of Government and Public Policy, University of Strathclyde, Glasgow, United Kingdom
| | - Anthony Anderson
- School of Psychological Sciences and Health, University of Strathclyde, Glasgow, United Kingdom
| | - Narisong Huhe
- School of Government and Public Policy, University of Strathclyde, Glasgow, United Kingdom
| | - David N. Rapp
- Department of Psychology, Northwestern University, Evanston, Illinois, IL, United States
- School of Education and Social Policy, Northwestern University, Evanston, IL, United States
| | - Jens K. Madsen
- Department of Psychological and Behavioural Science, London School of Economics and Political Science, London, United Kingdom
| |
Collapse
|
8
|
Hayden KM, Anderson A, Spira AP, St-Onge MP, Ding J, Culkin M, Molina-Henry D, Sanderlin AH, Reboussin D, Bahnson J, Espeland MA. Daytime Sleepiness Is Associated with Lower Cognitive Scores: The Look AHEAD Study. JAR Life 2023; 12:46-55. [PMID: 37457508 PMCID: PMC10345450 DOI: 10.14283/jarlife.2023.9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 05/11/2023] [Accepted: 05/12/2023] [Indexed: 07/18/2023]
Abstract
Background Daytime sleepiness is common in older adults and may result from poor nighttime sleep due to sleep disordered breathing, fragmented sleep, or other sleep disorders. Daytime sleepiness may be associated with cognition in older adults. Objectives We investigated the association between self-reported daytime sleepiness and cognitive function in the Look AHEAD clinical trial. Design Observational follow-up of a randomized clinical trial of an intensive lifestyle intervention. Setting Clinic. Participants Participants (n=1,778) aged 45-76 years at baseline with type 2 diabetes and overweight or obesity. Interventions Participants were randomized to an intensive lifestyle intervention for weight loss or a control condition of diabetes support and education. Measurements Participants provided self-reported levels of daytime sleepiness at baseline and years 12-13. Cognitive function was assessed with a neurocognitive battery at years 12-13 and 18-20. Results Participants who reported having frequent daytime sleepiness (often or always) performed significantly worse than others on the cognitive composite (-0.35; p-value=0.014) after controlling for covariates. When stratified by intervention arm, participants assigned to the intensive lifestyle intervention who reported often/always having daytime sleepiness performed worse on Digit Symbol Coding (-0.63; p-value=0.05) and Trail Making Part-B (-0.56; p-value=0.02) after controlling for covariates. Statistical interactions revealed associations between daytime sleepiness and the following covariates: race and ethnicity, APOE ε4 carrier status, baseline history of cardiovascular disease, and depression. Conclusions Daytime sleepiness over ~13 years predicted poorer cognitive performance in older individuals who, by virtue of having diabetes and overweight/obesity, are at high risk for sleep disorders and cognitive impairment.
Collapse
Affiliation(s)
- K M Hayden
- Department of Social Sciences and Health Policy, Wake Forest University School of Medicine, Winston-Salem, NC, USA
| | - A Anderson
- Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC, USA
| | - A P Spira
- Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA
- Johns Hopkins Center on Aging and Health, Baltimore, MD, USA
| | - M-P St-Onge
- Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA
| | - J Ding
- Department of Internal Medicine, Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA
| | - M Culkin
- Department of Social Sciences and Health Policy, Wake Forest University School of Medicine, Winston-Salem, NC, USA
| | - D Molina-Henry
- Winston-Salem State University, Winston-Salem, NC, USA
- University of Southern California, Alzheimer's Therapeutic Research Institute, San Diego, CA, USA
| | - A H Sanderlin
- Department of Internal Medicine, Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA
- Department of Biology, North Carolina Agricultural and Technical State University, Greensboro, NC, USA
| | - D Reboussin
- Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC, USA
| | - J Bahnson
- Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC, USA
| | - M A Espeland
- Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC, USA
- Department of Internal Medicine, Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA
| |
Collapse
|
9
|
Shephard MP, Robertson DJ, Huhe N, Anderson A. Everyday non-partisan fake news: Sharing behavior, platform specificity, and detection. Front Psychol 2023; 14:1118407. [PMID: 37255519 PMCID: PMC10225687 DOI: 10.3389/fpsyg.2023.1118407] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2022] [Accepted: 03/15/2023] [Indexed: 06/01/2023] Open
Abstract
Concern over the impact of fake news on major socio-political events is growing. The use of deliberate misinformation is thought to have played a role in the outcome of the UK EU referendum, the 2016 US presidential election, and in the effectiveness of COVID-19 public health messaging. As a result, recent research has tended to focus on hyper-partisan (e.g., US politics; Democrat/Republican), person specific (e.g., Hillary Clinton/Donald Trump) content that incorporates emotive and hyperbolic language. However, in this study, we focus on an alternative form of fake news, across a variety of topics (e.g., Crime, Immigration, and Health), that avoids these characteristics, and which may therefore be more pervasive and difficult to detect. In a three-part study, we examined participants sharing intentions for fake news (including platform preference; Facebook, Twitter, Instagram, and WhatsApp), their ability to explicitly detect fake news, and whether individual differences on psychological measures of critical thinking ability, rational thinking, and emotional stability predict sharing behavior and detection ability. The results show that even our well-informed sample (political science students) were not immune to the effects of fake news, some issues (e.g., health and crime) were more likely to be shared than others (e.g., immigration), and on specific platforms (e.g., Twitter, Facebook). In addition, we show that individual differences in emotional stability appears to be a key factor in sharing behavior, while rational thinking aptitude was key to fake news detection. Taken together, this study provides novel data that can be used to support targeted fake news interventions, suggesting possible news topic, sharing behavior, and platform specific insights. Such interventions, and implications for government policy, education, and social media companies are discussed.
Collapse
Affiliation(s)
- Mark P. Shephard
- School of Government and Public Policy, University of Strathclyde, Glasgow, United Kingdom
| | - David J. Robertson
- School of Psychological Sciences and Health, University of Strathclyde, Glasgow, United Kingdom
| | - Narisong Huhe
- School of Government and Public Policy, University of Strathclyde, Glasgow, United Kingdom
| | - Anthony Anderson
- School of Psychological Sciences and Health, University of Strathclyde, Glasgow, United Kingdom
| |
Collapse
|
10
|
Wadaan MA, Baabbad A, Khan MF, Saravanan M, Anderson A. Phytochemical profiling, anti-hyperglycemic, antifungal, and radicals scavenging potential of crude extracts of Athyrium asplenioides- an in-vitro approach. Environ Res 2023; 231:116129. [PMID: 37187305 DOI: 10.1016/j.envres.2023.116129] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/24/2023] [Revised: 05/10/2023] [Accepted: 05/12/2023] [Indexed: 05/17/2023]
Abstract
This research was aimed to evaluate the phytochemical profile, antifungal, anti-hyperglycemic, as well as antioxidant activity competence of different extracts of Athyrium asplenioides through in-vitro approach. The A. asplenioides crude methanol extract contained considerable quantity of pharmaceutically precious phytochemicals (saponins, tannins, quinones, flavonoid, phenols, steroid, and terpenoids) than others (acetone, ethyl acetate, and chloroform). Interestingly, the crude methanol extract showed remarkable antifungal activity against Candida species (C. krusei: 19.3 ± 2 mm > C. tropicalis: 18.4 ± 1 mm > C. albicans: 16.5 ± 1 mm > C. parapsilosis: 15.5 ± 2 mm > C. glabrate: 13.5 ± 2 mm > C. auris: 7.6 ± 1 mm) at a concentration of 20 mg mL-1. The crude methanol extract also showed remarkable anti-hyperglycemic activity on concentration basis. Surprisingly, remarkable free radicals scavenging potential against DPPH (76.38%) and ABTS (76.28%) free radicals at a concentration of 20 mg mL-1. According to the findings, the A. asplenioides crude methanol extract contains pharmaceutically valuable phytochemicals and may be useful for drug discovery.
Collapse
Affiliation(s)
- Mohammad Ahmad Wadaan
- Bio-Products Research Chair, Department of Zoology, College of Sciences, King Saud University, P.O. Box, 2455, Riyadh, 11451, Saudi Arabia.
| | - Almohannad Baabbad
- Bio-Products Research Chair, Department of Zoology, College of Sciences, King Saud University, P.O. Box, 2455, Riyadh, 11451, Saudi Arabia
| | - Muhammad Farooq Khan
- Bio-Products Research Chair, Department of Zoology, College of Sciences, King Saud University, P.O. Box, 2455, Riyadh, 11451, Saudi Arabia
| | - Mythili Saravanan
- Department of Pharmaceutical Sciences, North Carolina Central University, USA
| | - A Anderson
- Faculty of Science of Engineering, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, 600119, India.
| |
Collapse
|
11
|
Anderson A, Kumar M V, Gavurová B, Li H, Xia C, Zhang X. Optimizing engine performance and reducing emissions of greenhouse gases through spirulina microalgae and nano-additive blends. Environ Res 2023:115958. [PMID: 37086880 DOI: 10.1016/j.envres.2023.115958] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/29/2022] [Revised: 04/10/2023] [Accepted: 04/19/2023] [Indexed: 05/03/2023]
Abstract
The shift in focus towards biofuels has led to the attention towards fourth-generation fuels, particularly microalgae, due to its high oil productivity and simple cultivation processes. The current study aimed to examine the effects of spirulina microalgae blends in a naturally aspirated diesel engine by testing two blend percentages (15% and 30%) and incorporating Fe2O3 nanoparticles (75 ppm). A series of test conducted in a single-cylinder engine with an optimum compression ratio of 17.5. The fuels tested include 100% diesel (D0), diesel with Fe2O3 nanoparticles (DF), diesel with 15% microalgae blends (B15), diesel with 15% microalgae blends and Fe2O3 nanoparticles (B15F), diesel with 30% microalgae blends (B30), and diesel with 30% microalgae blends and Fe2O3 nanoparticles (B30F). The results showed that the addition of microalgae blends led to a marginal increase in engine performance, while the addition of Fe2O3 nanoparticles led to a significant increase in brake thermal efficiency and decreased fuel consumption. The emissions rate was also lower compared to diesel, but the addition of Fe2O3 nanoparticles increased the oxygen content in the fuel, thereby improving the combustion rates. By ensuring the complete combustion the formation of CO2, HC and smoke intensity was also found to be significantly lower compared to diesel fuel. On the contrary, NOx increased due to the cylinder temperatures. This research highlights the potential of using microalgae as a sustainable source of biofuel, and the positive effects of adding Fe2O3 nanoparticles to enhance the fuel's efficiency.
Collapse
Affiliation(s)
- A Anderson
- School of Mechanical Engineering, Sathyabama Institute of Science and Technology, India
| | - Vignesh Kumar M
- Department of Aerospace Engineering, SRM Institute of Science and Technology, India
| | - Beata Gavurová
- Technical University of Košice, Faculty of Mining, Ecology, Process Control and Geotechnologies, Letná 1/9, 042 00, Košice-Sever, Slovak Republic
| | - Hui Li
- College of Electrical and Electronic Engineering, Changchun University of Technology, Changchun, Jilin, 130012, China
| | - Changlei Xia
- College of Materials Science and Engineering, Nanjing Forestry University, Nanjing, Jiangsu, 210037, China
| | - Xiumei Zhang
- College of Materials Science and Engineering, Nanjing Forestry University, Nanjing, Jiangsu, 210037, China.
| |
Collapse
|
12
|
De Montalembert M, Anderson A, Costa F, Jastaniah W, Kuntz J, Odame I, Alfa Cissé O, Beaubrun A, Lartey B, Inusa B. Étude SHAPE (Sickle cell Health Awareness, Perspectives and Experience) : résultats de l’enquête sur le fardeau de la drépanocytose pour les patients et leurs besoins non satisfaits, rapportés par les professionnels de santé. Rev Med Interne 2022. [DOI: 10.1016/j.revmed.2022.10.152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
13
|
Odame I, Anderson A, Costa F, Inusa B, Jastaniah W, Kuntz J, Alkhadem Z, Tinga B, Ba D, Ingoli E, James J, Clark A, Alfa Cissé O, Beaubrun A, Lartey B, De Montalembert M. Étude SHAPE (Sickle Cell Health Awareness, Perspectives and Experiences) : enquête sur le fardeau de la drépanocytose et les besoins non satisfaits rapportés par les patients et les aidants. Rev Med Interne 2022. [DOI: 10.1016/j.revmed.2022.10.151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
14
|
Nguyen M, Beidler P, Lybarger K, Anderson A, Holmberg O, Kang J, Ford E. Automatic Prediction of Severity Score of Incident Learning Reports in Radiation Oncology Using Natural Language Processing. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.510] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
15
|
Anderson A. CLINICAL SUCCESS WITH A SHORT TWO DAY TRAINING COURSE. Fertil Steril 2022. [DOI: 10.1016/j.fertnstert.2022.09.267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
16
|
Costa FF, Montalembert M, Anderson A, Jastaniah W, Kunz JB, Odame I, Beaubrun A, Montealegre-Golcher F, Lartey B, Inusa BPD. PERSPECTIVAS DOS MÉDICOS BRASILEIROS SOBRE A DOENÇA FALCIFORME E SEU TRATAMENTO: RESULTADOS DA PESQUISA DE CONHECIMENTO, PERSPECTIVAS E EXPERIÊNCIAS EM SAÚDE DA DOENÇA FALCIFORME (SICKLE CELL HEALTH AWARENESS, PERSPECTIVES AND EXPERIENCES, SHAPE). Hematol Transfus Cell Ther 2022. [DOI: 10.1016/j.htct.2022.09.050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
|
17
|
Costa FF, Odame I, Anderson A, Inusa BPD, Jastaniah W, Kunz JB, Soares MZ, Montealegre-Golcher F, Lartey B, Montalembert M. IMPACTO DA DOENÇA FALCIFORME NA QUALIDADE DE VIDA DE PACIENTES BRASILEIROS E SEUS CUIDADORES: ACHADOS DA PESQUISA DE PERCEPÇÃO, PERSPECTIVAS E EXPERIÊNCIAS EM SAÚDE FALCIFORME. Hematol Transfus Cell Ther 2022. [DOI: 10.1016/j.htct.2022.09.052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
|
18
|
Pacella G, Anderson A, Ko E, Capell B. 510 The role of histone demethylase UTX on epidermal homeostasis and carcinogenesis. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.519] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
19
|
López AMM, Huang S, Anderson A, Capell B. 506 Epidermal epitranscriptomics: METTL3 dependent m6A maintains the epidermal stem cell state through regulation of chromatin-modifying enzymes. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
20
|
Bourke S, Palmer E, Echevarria C, Anderson A, Doe S, Brodlie M, Ward C. P200 The prevalence of laryngopharyngeal reflux and sino-nasal symptoms in adults with cystic fibrosis. J Cyst Fibros 2022. [DOI: 10.1016/s1569-1993(22)00529-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
21
|
Anderson A, Anbarasu A, Pasupuleti RR, Manigandan S, Praveenkumar TR, Aravind Kumar J. Treatment of heavy metals containing wastewater using biodegradable adsorbents: A review of mechanism and future trends. Chemosphere 2022; 295:133724. [PMID: 35101432 DOI: 10.1016/j.chemosphere.2022.133724] [Citation(s) in RCA: 25] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/30/2021] [Revised: 01/16/2022] [Accepted: 01/20/2022] [Indexed: 05/27/2023]
Abstract
The direct disposal of industrial effluents into the aquatic system is considered as a significant environmental hazard in many countries. Because of poisonous chemicals, substantial volumes of effluent release, as well as the lack of adequate of conventional treatment methodologies, industrial effluent treatment is extremely difficult. Numerous researchers have been interested in adsorption technology for its high efficiency of pollutant removal, low cost, and abundantly available adsorbent. Various adsorbent materials, both natural and modified form, have been widely used for the removal of toxic contaminants from industrial effluent. This paper highlights recent advancements in multiple modification types to functionalize the adsorbent material, resulting in higher adsorption capacity on various toxic pollutants. This review provides an overview of the adsorption mechanism and parameters (pH, adsorbent dosage, initial concentration, temperature and interaction time), which influencing the removal efficiency of adsorbents. Furthermore, this review compiles the desorption study to recover the adsorbent and improve the cycle's financial viability. This review provides a concise overview of the future directions and outlook in the framework of adsorbent application for industrial wastewater treatment.
Collapse
Affiliation(s)
- A Anderson
- Department of Aeronautical Engineering, Sathyabama Institute of Science and Technology, Chennai, 119, India
| | - A Anbarasu
- Department of Mechanical Engineering, Panimalar Engineering College, 600123, India
| | - Raghavendra Rao Pasupuleti
- Department of Medical Laboratory Science and Biotechnology, Kaohsiung Medical University, Kaohsiung, Taiwan
| | - Sekar Manigandan
- Department of Aeronautical Engineering, Sathyabama Institute of Science and Technology, Chennai, 119, India.
| | - T R Praveenkumar
- Department of Construction Technology and Management, Wollega University, Nekemte, Ethiopia.
| | - J Aravind Kumar
- Department of Energy and Environmental Engineering, Saveetha School of Engineering, SIMATS, Chennai, 602105, Tamilnadu, India
| |
Collapse
|
22
|
Hariharan MK, Anderson A, Raghavan K, Nithya S. Hot corrosion behaviour of Hastelloy X and Inconel 625 in an aggressive environment for superalloys for high-temperature energy applications. Appl Nanosci 2022. [DOI: 10.1007/s13204-021-02077-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
23
|
Smith S, Godley S, Miller P, Anderson A, Heap S. Expanding physiotherapy placement capacity: Clinical educators’ experiences of implementing a coaching approach to supervision. Physiotherapy 2022. [DOI: 10.1016/j.physio.2021.12.321] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
24
|
Tilton E, Mitchelson B, Anderson A, Peat B, Jack S, Lund M, Webb R, Wilson N. New Zealand Rheumatic Heart Disease Registry. Heart Lung Circ 2022. [DOI: 10.1016/j.hlc.2022.06.461] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
25
|
Kado J, Salman S, Hla T, Enkel S, Henderson R, Hand R, Hort A, Bennett J, Anderson A, Page-Sharp M, Batty K, Carapetis J, Manning L. Subcutaneous Infusions of High-Dose Benzathine Penicillin G (SCIP) is Safe, Tolerable and Potentially Suitable for Less Frequent Dosing for Rheumatic Heart Disease Secondary Prophylaxis. Heart Lung Circ 2022. [DOI: 10.1016/j.hlc.2022.06.515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
26
|
Preston S, Anderson A, Robertson DJ, Shephard MP, Huhe N. Correction: Detecting fake news on Facebook: The role of emotional intelligence. PLoS One 2021; 16:e0258719. [PMID: 34644360 PMCID: PMC8513819 DOI: 10.1371/journal.pone.0258719] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
27
|
Skoulidis F, Schuler M, Wolf J, Barlesi F, Price T, Dy G, Govindan R, Borghaei H, Falchook G, Li B, Ramalingam S, Sacher A, Spira A, Takahashi T, Anderson A, Ang A, Dai T, Flesher D, Cifuentes P, Velcheti V. MA14.03 Genomic Profiles and Potential Determinants of Response and Resistance in KRAS p.G12C-mutated NSCLC Treated With Sotorasib. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.08.184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
28
|
O'Gorman C, Khoury R, Anderson A, Carter M, DiCesare F, Dubé S, Ereshefsky L, Grossberg G, Hefting N, Khan S, Lind S, Moebius H, Shiovitz T, Rosenberg P. A Framework for Developing Pharmacotherapy for Agitation in Alzheimer's Disease: Recommendations of the ISCTM* Working Group. J Prev Alzheimers Dis 2021; 7:274-282. [PMID: 32920630 DOI: 10.14283/jpad.2020.37] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Dementia is characterized by a significant decline in one of several cognitive domains such as memory, language and executive function, affecting independence and representing a significant deterioration from a previous level of functioning (1). Alzheimer’s Disease (AD) represents the most common form of dementia and contributes up to 70% of the almost 50 million dementia cases worldwide, a number that is projected to double in 20 years (2).
Collapse
Affiliation(s)
- C O'Gorman
- Cedric O'Gorman MD, 200 Broadway (3rd Floor), New York, NY 10038, USA,
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Keegan N, Schonhoft J, Barnett E, Cohn E, Zhao J, Carbone E, Zanone M, Anderson A, Wenstrup R, Scher H. 613P Chromosomal instability (CIN) biomarker in circulating tumor cells (CTC) may predict for therapy resistance in metastatic castration-resistant prostate cancer (mCRPC). Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
30
|
Gomes VCL, Del Piero F, Langohr IM, Aguiar LH, Anderson A, Sones JL, Pinto CR. Equine focal mucopurulent placentitis associated with
Stenotrophomonas maltophilia. EQUINE VET EDUC 2021. [DOI: 10.1111/eve.13310] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- V. C. L. Gomes
- Department of Veterinary Clinical Sciences Louisiana State University Baton Rouge LouisianaUSA
| | - F. Del Piero
- Department of Pathobiological Sciences School of Veterinary Medicine Louisiana State University Baton Rouge Louisiana USA
| | - I. M. Langohr
- Department of Pathobiological Sciences School of Veterinary Medicine Louisiana State University Baton Rouge Louisiana USA
| | - L. H. Aguiar
- Department of Veterinary Clinical Sciences Louisiana State University Baton Rouge LouisianaUSA
| | - A. Anderson
- Department of Pathobiological Sciences School of Veterinary Medicine Louisiana State University Baton Rouge Louisiana USA
| | - J. L. Sones
- Department of Veterinary Clinical Sciences Louisiana State University Baton Rouge LouisianaUSA
| | - C. R. Pinto
- Department of Veterinary Clinical Sciences Louisiana State University Baton Rouge LouisianaUSA
| |
Collapse
|
31
|
Zhao J, Antonarakis E, Cheng H, George D, Aggarwal R, Abida W, Decker B, Smart-Curley T, Schonhoft J, Anderson A, Haywood S, Riedel E, Carver B, Wyatt A, Feng F, Knudsen K, Rathkopf D. 598P A phase Ib study of enzalutamide (Enza) plus CC-115 in men with metastatic castration-resistant prostate cancer (mCRPC). Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1111] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
32
|
Senthilkumar A, Anderson A, Sekar M. Performance analysis of R600a vapour compression refrigeration system using CuO/Al2O3 hybrid nanolubricants. Appl Nanosci 2021. [DOI: 10.1007/s13204-021-01936-y] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
33
|
Brown P, Anderson A, Hargreaves B, Morgan A, Isaacs JD, Pratt A. OP0033 REGULATORY T CELL CD39 EXPRESSION AS A PREDICTOR OF EARLY REMISSION-INDUCTION WITH METHOTREXATE IN NEW-ONSET RHEUMATOID ARTHRITIS. Ann Rheum Dis 2021. [DOI: 10.1136/annrheumdis-2021-eular.2030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:The long term outcomes for patients with rheumatoid arthritis (RA) depend on early and effective disease control. Methotrexate remains the key first line disease modifying therapy for the majority of patients, with 40% achieving an ACR50 on monotherapy(1). There are at present no effective biomarkers to predict treatment response, preventing effective personalisation of therapy. A putative mechanism of action of methotrexate, the potentiation of anti-inflammatory adenosine signalling, may inform biomarker discovery. By antagonism of the ATIC enzyme in the purine synthesis pathway, methotrexate has been proposed to increase the release of adenosine moieties from cells, which exert an anti-inflammatory effect through interaction with ADORA2 receptors(2). Lower expression of CD39 (a cell surface 5-’ectonucleotidase required for the first step in the conversion of ATP to adenosine) on circulating regulatory T-Lymphocytes (Tregs) was previously identified in patients already established on methotrexate who were not responding (DAS28 >4.0 vs <3.0)(3). We therefore hypothesised that pre-treatment CD39 expression on these cells may have clinical utility as a predictor of early methotrexate efficacy.Objectives:To characterise CD39 expression in peripheral blood mononuclear cells in RA patients naïve to disease modifying therapy commencing methotrexate, and relate this expression to 4 variable DAS28CRP remission (<2.6) at 6 months.Methods:68 treatment naïve early RA patients starting methotrexate were recruited from the Newcastle Early Arthritis Clinic and followed up for 6 months. Serial blood samples were taken before and during methotrexate therapy with peripheral blood mononuclear cells isolated by density centrifugation. Expression of CD39 by major immune subsets (CD4+ and CD8+ T-cells, B-lymphocytes, natural killer cells and monocytes) was determined by flow cytometry. The statistical analysis used was binomial logistic regression with baseline DAS28CRP used as a covariate due to the significant association of baseline disease activity with treatment response.Results:Higher pre-treatment CD39 expression was observed in circulating CD4+ T-cells of patients who subsequently achieved clinical remission at 6 months versus those who did not (median fluorescence 4854.0 vs 3324.2; p = 0.0108; Figure 1-A). This CD39 expression pattern was primarily accounted for by the CD4+CD25 high sub-population (median fluorescence 9804.7 vs 6455.5; p = 0.0065; Figure 1-B). These CD25 high cells were observed to have higher FoxP3 and lower CD127 expression than their CD39 negative counterparts, indicating a Treg phenotype. No significant associations were observed with any other circulating subset. A ROC curve demonstrates the discriminative utility of differential CD39 expression in the CD4+CD25 high population for the prediction of DAS28CRP remission in this cohort, showing greater specificity than sensitivity for remission prediction(AUC: 0.725; 95% CI: 0.53 - 0.92; Figure 1-C). Longitudinally, no significant induction or suppression of the CD39 marker was observed amongst patients who did or did not achieve remission over the 6 months follow-up period.Figure 1.Six month DAS28CRP remission versus pre-treatment median fluorescence of CD39 expression on CD4+ T-cells (A); CD25 High expressing CD4+ T-cells (B); and ROC curve of predictive utility of pre-treatment CD39 expression on CD25 High CD4+ T-cells (C).Conclusion:These findings support the potential role of CD39 in the mechanism of methotrexate response. Expression of CD39 on circulating Tregs in treatment-naïve RA patients may have particular value in identifying early RA patients likely to respond to methotrexate, and hence add value to evolving multi-parameter discriminatory algorithms.References:[1]Hazlewood GS, et al. BMJ. 2016 21;353:i1777[2]Brown PM, et al. Nat Rev Rheumatol. 2016;12(12):731-742[3]Peres RS, et al. Proc Natl Acad Sci U S A. 2015;112(8):2509-2514Disclosure of Interests:None declared
Collapse
|
34
|
Swift J, Stanway J, Nicorescu I, Hilkens C, Stevenaert F, Anderson A, Pratt A, Isaacs JD. AB0025 CITRULLINATED-PEPTIDE SPECIFIC CD4+ T CELL RESPONSES IN RHEUMATOID ARHRITIS. Ann Rheum Dis 2021. [DOI: 10.1136/annrheumdis-2021-eular.2652] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:CD4+ T cells reacting to post-translationally modified, citrullinated self-antigens are thought to play a central role in the pathogenesis of rheumatoid arthritis (RA)1. This is evidenced by a strong HLA class II association, the success of therapeutic co-stimulation blockade and the detection of autoantigen specific T-cells using HLA class II multimers2. These cells may represent a target for antigen-specific, tolerogenic therapies and their in-depth phenotyping may provide the means by which to monitor such treatment.Objectives:To identify the citrullinated-peptide (cit-peptide) induced cytokine repertoire of antigen-specific memory CD4+ T cells in both healthy controls (HCs) and ACPA positive RA patients using intracellular cytokine staining and flow cytometry. Of note, the HLA-types of both HCs and RA patients were not known.Methods:Cryopreserved peripheral blood mononuclear cells (PBMC) from both HCs (n = 8) and RA patients (n = 13) with both early (untreated) and established disease were thawed and labelled with a proliferation tracking dye (PTD). Labelled PBMC were then either incubated alone or with a pool of cit-peptides for 9-days, followed by a 5-hour restimulation with PMA and ionomycin, where cytokine secretion was blocked for the final 4-hours using brefeldin-A. Cells were then harvested, permeabilised and stained for T cell surface markers and intracellular cytokines including IFN-γ, IL-4, IL-21 and IL-17. Stained cells were immediately acquired using a BD Fortessa X20, where antigen-specific CD4+ T cells were identified as the viable CD45RO+ (memory) CD4+ T cell population that had proliferated (PTDlow) in response to the cit-peptides. Stimulation indices (SI) were calculated as the percentage of proliferated memory CD4+ T cells in the stimulated wells divided by the percentage in the unstimulated conditions, and cit-peptide responders were defined as those with an SI > 2.0. Net cytokine production was measured by subtracting the percentage cytokine production from unstimulated CD4+ CD45RO+ PTDlow cells, from those stimulated with the cit-peptides.Results:Comparable proliferative responses were observed in both donor groups in response to stimulation with the cit-peptide pool, where 37 % of HCs and 31 % of RA patients responded with an SI > 2.0 (Fig. 1A). While little cytokine production was observed in the cit-peptide responding HC T cells, for responding RA donors, cit-peptide responsive CD4+ memory T cells were predominantly IFN-γ and IL-21 producing (Fig. 1B and 1C). In contrast, these donors did not produce significant levels of either IL-17 or IL-4 (Fig. 1D and 1E).Conclusion:Cit-peptides were able to induce proliferation in both HCs and RA memory CD4+ T cells which, amongst the RA donors only, were of a Th1/Tfh subtype. In contrast, and while based only on a small sample, cit-peptides did not induce either IL-17 or IL-4 production in either donor group, suggesting a lack of Th17/Th2 responses. Not all donors responded to the peptide pool, possibly reflecting the limited number of pooled cit-peptides or to a lack of confirmed HLA-DRB1*04:01 positive donors, as peptides were selected for their specificity on this basis. Future work will therefore include HLA-typing, as well as the inclusion of additional citrullinated-epitopes to demonstrate autoreactivity in a wider cross-section of patients. Further phenotyping of the cit-peptide specific T cells will be performed, and future plans will be to study the assay data alongside clinical outcomes to assess its value for immune monitoring.References:[1]Malmström, V et al Nat Rev Immunol. 2017; 17(1):60-75.[2]Gerstner, C et al BMC Immunol. 2020; 21(27):1-14.Disclosure of Interests:Jessica Swift: None declared, James Stanway: None declared, Ioana Nicorescu: None declared, Catharien Hilkens: None declared, Frederik Stevenaert Employee of: Janssen, Amy Anderson Grant/research support from: Pfizer, GSK and Janssen, Arthur Pratt Grant/research support from: Pfizer, GSK and Janssen, John D Isaacs Speakers bureau: Abbvie, Gilead, Roche, UC, Consultant of: Abbvie, Gilead, Roche, UC, Grant/research support from: Pfizer, GSK and JanssenFigure 1.Citrullinated-peptide specific memory CD4+ T cell proliferation (A) and net % cytokine production of IFN-γ (B), IL-21 (C), IL-17 (D) and IL-4 (E) positive cells.
Collapse
|
35
|
Maldonado López A, Aubert Y, Anderson A, Ko E, Liu F, Capell B. 165 Elucidating the METTL3-m6A epitranscriptome in epidermal development and carcinogenesis. J Invest Dermatol 2021. [DOI: 10.1016/j.jid.2021.02.185] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
36
|
York JD, Colsky J, Croft K, Segalewitz T, DiBiase L, Anderson A, Palaez A, Shahmohammadi A, Pipkin M, Machuca T, Plowman E. Dysphagia in Lung Transplant Recipients: Prevalence, Risk Factors and Health-Related Outcomes. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.985] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
37
|
Segalewitz T, Colsky J, York JD, Croft K, DiBiase L, Anderson A, Pelaez A, Shahmohammadi A, Pipkin M, Machuca T, Plowman E. Is Dysphagia a Pre-Existing Condition in Individuals Undergoing Lung Transplantation? Radiographic Swallowing Safety Profiles before and after Lung Transplantation. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.983] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
38
|
Preston S, Anderson A, Robertson DJ, Shephard MP, Huhe N. Detecting fake news on Facebook: The role of emotional intelligence. PLoS One 2021; 16:e0246757. [PMID: 33705405 PMCID: PMC7951906 DOI: 10.1371/journal.pone.0246757] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2020] [Accepted: 01/25/2021] [Indexed: 11/19/2022] Open
Abstract
The proliferation of fake news on social media is now a matter of considerable public and governmental concern. In 2016, the UK EU referendum and the US Presidential election were both marked by social media misinformation campaigns, which have subsequently reduced trust in democratic processes. More recently, during the COVID-19 pandemic, the acceptance of fake news has been shown to pose a threat to public health. Research on how to combat the false acceptance of fake news is still in its infancy. However, recent studies have started to focus on the psychological factors which might make some individuals less likely to fall for fake news. Here, we adopt that approach to assess whether individuals who show high levels of 'emotional intelligence' (EQ) are less likely to fall for fake news items. That is, are individuals who are better able to disregard the emotionally charged content of such items, better equipped to assess the veracity of the information. Using a sample of UK participants, an established measure of EQ and a novel fake news detection task, we report a significant positive relationship between individual differences in emotional intelligence and fake news detection ability. We also report a similar effect for higher levels of educational attainment, and we report some exploratory qualitative fake news judgement data. Our findings are discussed in terms of their applicability to practical short term (i.e. current Facebook user data) and medium term (i.e. emotional intelligence training) interventions which could enhance fake news detection.
Collapse
Affiliation(s)
- Stephanie Preston
- School of Psychological Sciences and Health, University of Strathclyde, Glasgow, United Kingdom
| | - Anthony Anderson
- School of Psychological Sciences and Health, University of Strathclyde, Glasgow, United Kingdom
| | - David J. Robertson
- School of Psychological Sciences and Health, University of Strathclyde, Glasgow, United Kingdom
| | - Mark P. Shephard
- School of Government and Public Policy, University of Glasgow, Glasgow, United Kingdom
| | - Narisong Huhe
- School of Government and Public Policy, University of Glasgow, Glasgow, United Kingdom
| |
Collapse
|
39
|
Dawson S, Carolan C, Daniels T, Lee K, Anderson A, Choyce J, Gledhill H, Warnock L, Moran P, Wildman M. P235 Using a 1,500-patient learning health system (LHS) to support virtual clinics and medicines optimisation: a UK seven-centre Patient and Public Involvement (PPI) project to understand user experience. J Cyst Fibros 2021. [DOI: 10.1016/s1569-1993(21)01260-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
40
|
Hong D, Bang YJ, Barlesi F, Durm G, Falchook G, Govindan R, Dy G, Park K, Strickler J, Burns T, Kim J, Ang A, Lipford J, Ngarmchamnanrith G, Anderson A, Li B. MO01.31 Durability of Clinical Benefit and Biomarkers in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Sotorasib, a KRAS(G12C) Inhibitor. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2020.10.136] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
41
|
Carolan C, Dawson S, Cunningham J, Choyce J, Tugwell A, Faulkner J, Barnett T, Thomas M, Gledhill H, Anderson A, Tature D, Szczepanski R, Lowther M, Pickering N, Daniels T, Galey P, Wildman M. P217 Delivering quality improvement coaching in a virtual world: the use of digital technology to empower and engage CFDigiCare clinicians to undertake quality improvement activities nationally. J Cyst Fibros 2021. [DOI: 10.1016/s1569-1993(21)01242-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
42
|
Anderson A, Lazar A, Zhang M, Braunstein S. Predictors Of Survival For Patients With Leptomeningeal Metastases From Breast Cancer: A Single-Center Experience. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.2023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
43
|
Hong D, Bang YJ, Barlesi F, Durm G, Falchook G, Govindan R, Dy G, Park K, Strickler J, Burns T, Kim J, Ang A, Lipford J, Ngarmchamnanrith G, Anderson A, Li B. 1257O Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib). Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1571] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
44
|
Tulchin-Francis K, Stevens W, Anderson A, Jeans K. The Pedi-CHAMP Agility Test: Completion Rates For Typically Developing Children Aged 5 To 17yrs. Med Sci Sports Exerc 2020. [DOI: 10.1249/01.mss.0000675216.42524.6b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
45
|
Akaike T, Qazi J, Anderson A, Behnia FS, Shinohara MM, Akaike G, Hippe DS, Thomas H, Takagishi SR, Lachance K, Park SY, Tarabadkar ES, Iyer JG, Blom A, Parvathaneni U, Vesselle H, Nghiem P, Bhatia S. High somatostatin receptor expression and efficacy of somatostatin analogues in patients with metastatic Merkel cell carcinoma. Br J Dermatol 2020; 184:319-327. [PMID: 32320473 DOI: 10.1111/bjd.19150] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/17/2020] [Indexed: 12/11/2022]
Abstract
BACKGROUND Merkel cell carcinoma (MCC) is an aggressive, high-grade, cutaneous neuroendocrine tumour (NET). Agents blocking programmed death 1/programmed death ligand 1 have efficacy in metastatic MCC (mMCC), but half of patients do not derive durable benefit. Somatostatin analogues (SSAs) are commonly used to treat low- and moderate-grade NETs that express somatostatin receptors (SSTRs). OBJECTIVES To assess SSTR expression and the efficacy of SSAs in mMCC, a high-grade NET. Methods In this retrospective study of 40 patients with mMCC, SSTR expression was assessed radiologically by somatostatin receptor scintigraphy (SRS; n = 39) and/or immunohistochemically when feasible (n = 9). Nineteen patients (18 had SRS uptake in MCC tumours) were treated with SSA. Disease control was defined as progression-free survival (PFS) of ≥ 120 days after initiation of SSA. RESULTS Thirty-three of 39 patients (85%) had some degree (low 52%, moderate 23%, high 10%) of SRS uptake. Of 19 patients treated with SSA, seven had a response-evaluable target lesion; three of these seven patients (43%) experienced disease control, with a median PFS of 237 days (range 152-358). Twelve of 19 patients did not have a response-evaluable lesion due to antecedent radiation; five of these 12 (42%) experienced disease control (median PFS of 429 days, range 143-1757). The degree of SSTR expression (determined by SRS and/or immunohistochemistry) did not correlate significantly with the efficacy endpoints. CONCLUSIONS In contrast to other high-grade NETs, mMCC tumours appear frequently to express SSTRs. SSAs can lead to clinically meaningful disease control with minimal side-effects. Targeting of SSTRs using SSA or other novel approaches should be explored further for mMCC.
Collapse
Affiliation(s)
- T Akaike
- Division of Dermatology, Department of Medicine, University of Washington, Seattle, WA, USA
| | - J Qazi
- Division of Dermatology, Department of Medicine, University of Washington, Seattle, WA, USA
| | - A Anderson
- Division of Dermatology, Department of Medicine, University of Washington, Seattle, WA, USA
| | - F S Behnia
- Department of Radiology, University of Washington, Seattle, WA, USA
| | - M M Shinohara
- Division of Dermatology, Department of Medicine, University of Washington, Seattle, WA, USA
| | - G Akaike
- Department of Radiology, University of Washington, Seattle, WA, USA
| | - D S Hippe
- Department of Radiology, University of Washington, Seattle, WA, USA
| | - H Thomas
- Division of Dermatology, Department of Medicine, University of Washington, Seattle, WA, USA
| | - S R Takagishi
- Division of Dermatology, Department of Medicine, University of Washington, Seattle, WA, USA
| | - K Lachance
- Division of Dermatology, Department of Medicine, University of Washington, Seattle, WA, USA
| | - S Y Park
- Division of Dermatology, Department of Medicine, University of Washington, Seattle, WA, USA
| | - E S Tarabadkar
- Division of Dermatology, Department of Medicine, University of Washington, Seattle, WA, USA
| | - J G Iyer
- Division of Dermatology, Department of Medicine, University of Washington, Seattle, WA, USA
| | - A Blom
- Division of Dermatology, Department of Medicine, University of Washington, Seattle, WA, USA
| | - U Parvathaneni
- Department of Radiation Oncology, University of Washington, Seattle, WA, USA
| | - H Vesselle
- Department of Radiology, University of Washington, Seattle, WA, USA
| | - P Nghiem
- Division of Dermatology, Department of Medicine, University of Washington, Seattle, WA, USA.,Fred Hutchinson Cancer Research Center, Seattle, WA, USA
| | - S Bhatia
- Fred Hutchinson Cancer Research Center, Seattle, WA, USA.,Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA
| |
Collapse
|
46
|
Tariq F, Alobaidi B, Xavier M, Mccorkindale M, Veltman J, Isaacs J, Pratt A, Anderson A, Collin M. THU0026 CLONAL HAEMATOPOIESIS ASSOCIATED SOMATIC MUTATIONS IN RHEUMATOID ARTHRITIS. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.5568] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:Clonal haematopoiesis of indeterminate potential (CHIP) occurs when somatic mutations arise in myeloid neoplasia driver genes of haematopoietic progenitor cells, in the absence of overt cytopenia or dysplasia. The prevalence of CHIP increases with age. The most common genes affected by CHIP mutations in unselected populations are DNMT3A, ASXL1, and TET2. The presence of CHIP is linked to increased basal level of inflammation and a high risk of cardiovascular disease and all-cause mortality. Rheumatoid arthritis (RA) is one of the most common and debilitating multi-system autoimmune disorders, affecting up to 1% of adults in developed countries. The role of somatic mutations in the pathogenesis of autoimmune diseases is an unexplored area; therefore, we aimed to test the hypothesis that clonal haematopoiesis (CH) is associated with the incidence and severity of RA.Objectives:To evaluate the association of CH somatic mutation with severity of RA.Methods:163 RA patients were recruited from the following cohorts: (i)Early RA/treatment naive (n=31), (ii)Refractory RA - non-responders to Disease-Modifying Anti-Rheumatic Drugs (DMARDs) and biologics (n=48), (ii)Flare (n=41) vsRemission patients (n=43) –patients treated with DMARDs and withdrawn from treatment on achieving remission. Six months later, 50% relapse and 50% sustain remission. Single molecule molecular inversion probes (smMIPs) were used to screen for somatic mutations in 40 loci known to carry clonal haematopoiesis driver mutations (CHDMs). Whole exome sequencing was also performed on Flare/Remission patients (n = 84) to screen for CHDMs and other somatic mutations. In-house bioinformatics pipelines were used to call mutations from both the datasets.Results:We identified CH in RA with an overall prevalence of 14%. Twenty-four unique variants with a variant allele frequency (VAF) of 2-35% were found in ten genes including ASXL1, CBL, DNMT3A, GNAS, GNB1, PTPN11, PTPN12, SF3B1, TET2, and TP53. The number of unique patients carrying mutations in these genes are follows:refractory: n=12/48, flare: n=6/41,remission: n=4/43 andearly RA: n=2/31. The majority of the mutations occurred in DNMT3A (n=6) followed by TP53 (N=4) and TET2 (n=3). Two variants with VAF of 15% were identified in two patients under the age of 30, both with clinically severe disease. In patients between the ages of 50-59 yrs., 60-69 yrs., and 70-79 yrs., CH was observed at 11% (4/35), 23% (11/46) and 17%(7/41), respectively.Conclusion:We here report the prevalence of CH in RA, affecting more patients with clinically advanced/refractory disease compared to those with early/less severe disease.Further study will be conducted to confirm the results.References:[1]Acuna-Hidalgo, R., Sengul, H., Steehouwer, M., van de Vorst, M., Vermeulen, S., & Kiemeney, L. et al. (2017). Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life.The American Journal Of Human Genetics,101(1), 50-64. doi: 10.1016/j.ajhg.2017.05.013[2]NRAS - National Rheumatoid Arthritis Society. (2020). Retrieved 30 January 2020, fromhttps://www.nras.org.uk/what-is-ra-article[3]Steensma, D., Bejar, R., Jaiswal, S., Lindsley, R., Sekeres, M., Hasserjian, R., & Ebert, B. (2015). Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.Blood,126(1), 9-16. doi: 10.1182/blood-2015-03-631747Acknowledgments:National Institute for Health Research, United KingdomDisclosure of Interests:Fareeha Tariq: None declared, Bilal Alobaidi: None declared, Miguel Xavier: None declared, Michael McCorkindale: None declared, Joris Veltman: None declared, John Isaacs Consultant of: AbbVie, Bristol-Myers Squibb, Eli Lilly, Gilead, Janssen, Merck, Pfizer, Roche, Arthur Pratt Grant/research support from: Pfizer, GSK, Amy Anderson: None declared, Matthew Collin: None declared
Collapse
|
47
|
Maney N, De Paula-Lemos H, Barron-Millar B, Mellor A, Isaacs JD, Anderson A, Pratt A. SAT0013 PIM-1 KINASE IS A MEASURABLE MEDIATOR OF CD4+ T CELL DYSREGULATION AND THERAPEUTIC TARGET IN EARLY RHEUMATOID ARTHRITIS. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.2818] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:As well as being an established oncoprotein and a therapeutic target in cancer,Proviral Integration site for murine Moloney leukemia virus-1(pim-1) has been implicated in human autoimmunity. We previously confirmed this serine-threonine protein kinase to be strikingly upregulated in circulating CD4+ T cells of untreated rheumatoid arthritis (RA) patients as a consequence of IL-6 signalling1-2. Evidence for the relevance of pim-1 signalling in the disruption of RA synovial fibroblast (RASF) homeostasis3further supports its candidacy as a therapeutic target.Objectives:To investigate PIM1 and its family members (PIM2 and PIM3) as potential candidates for drug repurposing in RA.Methods:A flow cytometric assay for PIM1 transcript measurement in circulating CD4+ T cells of early arthritis patients was validated against real-time PCR in paired cells isolated by bead selection. Synovial protein expression in tissue from the same cohort of untreated RA patients and disease controls was determined by quantitative multiplex immunofluorescence. The functional consequences of manipulating pim kinase family expression in freshly purified T cell receptor (TCR)-stimulated CD4+ T cells from early RA patients was explored. The impact of pim-1 specific and pim-1-3 (pan-pim) kinase inhibition on progression of the IL-6 dependent collagen-induced arthritis (CIA) model was assessed.Results:The percentage of circulating CD4+ T cells positive forPIM1transcript by flow cytometry proved a faithful surrogate for gene expression in early arthritis (Figure 1A), distinguishing RA from other pathologies (Figure 1B). Pim-1 protein expression was increased in the synovium of untreated RA compared with disease controls, including amongst infiltrating CD4+ T cells (Figure 1C-D).In vitro, exposure of TCR-stimulated early RA CD4+ T cells to pim kinase inhibitors restrained their activation and proliferative capacity; diminished pro-inflammatory cytokine production (IFN-g and IL-17) and an expanded CD25hiFoxP3+ regulatory T cell (Treg) fraction were also observed in treatedversusun-treated cells. Finally, administration of pim inhibitors robustly attenuated clinical scores of arthritis in the CIA model, with reduced cartilage loss observed in animals treated with a pan-PIM inhibitor compared with vehicle control (Figure 2).Conclusion:Our data highlight pim kinases as plausible therapeutic targets for a subgroup of early RA patients that may be identifiable using tractable in vitro assays. Pim kinase inhibitors could simultaneously target immune inflammation and RASF dysregulation; consideration should now be given to their repurposing for this condition.References:[1] Anderson AE et al Annals of the Rheumatic Diseases 2016; 75:466-73.[2] Anderson AE et al Rheumatology 2019; 58:1250-1258[3] Ha YJ et al Rheumatology 2019; 58:154-64Disclosure of Interests:Nicola Maney Consultant of: Current employee of Eli Lilly, Henrique De Paula-Lemos: None declared, Ben Barron-Millar: None declared, Andrew Mellor Shareholder of: NewLink Genetics PLC, and has received patent licensing income from this source., John D Isaacs Consultant of: AbbVie, Bristol-Myers Squibb, Eli Lilly, Gilead, Janssen, Merck, Pfizer, Roche, Amy Anderson: None declared, Arthur Pratt Grant/research support from: Pfizer, GlaxoSmithKlein
Collapse
|
48
|
Swift J, Stanway J, Hilkens C, Anderson A, Pratt A, Isaacs J. OP0129 AUTOREACTIVE, CITRULLINATED PEPTIDE-SPECIFIC T CELLS IN RHEUMATOID ARTHRITIS. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.4687] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:Self-reactive CD4+ T cells are thought to play a key role in the pathogenesis of rheumatoid arthritis (RA) and represent a target for antigen-specific, tolerogenic therapies1. Phenotyping such cells could provide the means with which to monitor these treatments. Here, we aimed to demonstrate antigen-induced T cell responses to RA relevant epitopes using peptide stimulation of peripheral blood mononuclear cells (PBMC). Several autoantigens have been described in RA, including various citrullinated peptide (cit-peptide) epitopes2; here we have used a combination of cit-peptides that will be used to load tolerogenic dendritic cells in a forthcoming experimental medicine study (AuToDeCRA II).Objectives:To detect peripheral blood T cell proliferation in response to candidate autoantigens in RA patients and healthy controls (HCs) using flow cytometry.Methods:PBMC from RA patients and HCs were obtained following informed consent and were cryopreserved. Prior to use, cells were thawed in medium supplemented with human serum and were labelled with a proliferation tracking dye (PTD). 2x105labelled cells were plated into 96 well plates with a minimum of 7 replicates per condition and were either cultured alone or stimulated with individual peptides at varying concentrations or a peptide pool. On day 9, cells from replicate wells were harvested, pooled and stained for surface markers and viability. Samples were acquired on a BD Fortessa X20 and analysis was performed in FlowJo version 10. A manual gating strategy was used to identify CD45RO+ (memory) CD4+ T cells and amongst this population, activated/proliferated cells were defined as CD25+ PTD low. Stimulation indices (SI) were calculated as the percentage of activated/proliferated cells from stimulated wells divided by the percentage from unstimulated wells.Results:Ten RA patients (including early and established disease) were recruited alongside seven HCs. Cit-peptides were initially titrated on an individual basis to determine the optimum concentration for use (n = 2). We then compared stimulation with either single peptides or a pool (n = 2), and found that PBMC stimulated with the pooled cit-peptides had a higher proliferative response. Both single and pooled cit-peptide induced T cell proliferation was observed in both RA and HC samples (Figure 1); the largest responses were seen amongst RA patients, with a maximum stimulation index of 52.4 compared to a maximum of 6.75 in the HC group. Only 1 HC sample responded with an SI greater than 3.0, whereas 50 % of RA patients elicited responses above this. Two of the RA patients failed to respond to the peptide pool (SI < 1.0). Of note, RA patients were not selected on the basis of tissue type whereas selected peptides bind preferentially to class II HLA containing the shared epitope (SE).Figure 1Antigen-specific CD4+ CD45RO+ responses of citrullinated peptide stimulated PBMC from HCs and RA patients.Conclusion:In non-HLA typed individuals, cit-peptide induced proliferative T cell responses were detectable in both RA patients and HCs, and although SIs overall were higher amongst RA patients this did not reach statistical significance in this small sample. Not all RA patients responded to the peptide pool which may be due to the limited number of citrullinated epitopes used, or to RA patients with a non-SE HLA type. Additional work should establish the need for HLA typing in this assay; around half of seropositive RA patients would be expected to be SE positive3. Furthermore, a wider array of cit-peptides may be needed to demonstrate autoreactivity in a broader cross-section of RA patients. Our future plans are to further phenotype the cellular subsets responding to the peptide pool and to study assay data in the context of clinical outcomes, to assess its utility for immune monitoring.References:[1]McInnes, I. B. & Schett, G. N Engl J Med. 2011; 365(23):2205-2219[2]James, E. Aet al. Arthritis Rheum. 2014; 66(7):1712-1722[3]Thomson, Wet al. Arthritis Rheum. 1999; 42(4):757-762Disclosure of Interests:Jessica Swift: None declared, James Stanway: None declared, Catharien Hilkens: None declared, Amy Anderson: None declared, Arthur Pratt Grant/research support from: Pfizer, GlaxoSmithKlein, John Isaacs Consultant of: AbbVie, Bristol-Myers Squibb, Eli Lilly, Gilead, Janssen, Merck, Pfizer, Roche
Collapse
|
49
|
Clark A, Naamane N, Nair N, Anderson A, Thalayasingam N, Diboll J, Barton A, Eyre S, Isaacs JD, Reynard L, Pratt A. THU0005 VARIABILITY OF DNA METHYLATION IS A DRIVER OF LYMPHOCYTE DYSREGULATION IN EARLY RHEUMATOID ARTHRITIS. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.2852] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:DNA methylation patterns differ between leukocyte subsets and mediate the impact of environmental exposures on the molecular and functional phenotype of immune cells. Besides differences in mean methylation of CpG positions amongst patients with immune mediated diseases, recent evidence indicates variability of site-specific DNA methylation also contributes to pathogenesis1,2.Objectives:To seek evidence of altered DNA methylation patterns in RA, controlling for systemic inflammation and immunotherapy use.Methods:Patients with confirmed clinical diagnoses were enrolled from the Northeast Early Arthritis Cohort (NEAC). CD4+and CD19+lymphocytes were isolated from fresh blood by positive selection prior to therapeutic immune modulation. Methylation was quantified in cell subset-specific DNA (Infinium MethylationEPIC BeadChip, Illumina)3. Differentially methylated positions and regions (DMPs, DMRs) between RA and non-RA patients were identified (linear modelling, filtering on 5% pairwise difference in mean DNA methylation, and DMRcate package). Next, to identify instances where methylation variance differed between comparator groups, Bartlett’s test was performed using the iEVORA package, which accounts for outlier values4. Findings were controlled for technical confounders and subject to multiple test correction (FDR). A validated hypergeometric test was used to annotate enriched pathways.Results:After sample- and probe-level quality control, CD4+ and B lymphocyte specific data were respectively available for 45 and 49 RA patients, and 64 and 81 disease controls matched for systemic inflammation (CRP, ESR). No DMPs were identified in either cell type at FDR < 0.05 and Δβ ≥0.05. Only following relaxation of multiple test correction was it possible to identify DMRs in either cell type, most notably encapsulating 10 CpGs relatively hypomethylated at the promoter of the endosome protein-encodingRUFY1gene in CD4+ lymphocytes of RA patients (Δβ = 0.076). By contrast, striking evidence for differential variation in DNA methylation was observed at 291 and 601 CpGs of CD4+ and B lymphocytes, respectively (exemplars depicted in Figure 1). Only 15 of these differentially variable positions (DVPs) were common to both cell types. Pathway analysis highlighted potential functional consequences of DVP associations; for example, RA-specific hypervariability implicates prostaglandinsignalling in CD4+ lymphocytes.Conclusion:We highlight a role for altered variability in DNA methylation during the molecular pathogenesis of RA, and emphasise the importance of its study in relevant cell subsets.References:[1]Paul DSet al. Nature Communications 7, 13555 doi: 10.1038/ncomms13555 (2016).[2]Webster AP et al. Genome Medicine 10, 64 (2018)doi:10.1186/s13073-018-0575-9.[3]Clark AD et al. Journal of Allergy and Clinical Immunology 2019; doi: 10.1016/j.jaci.2019.12.910[4]Teschendorff AE et al. Nature Communications 2016; 7:12.Disclosure of Interests:Alexander Clark: None declared, Najib Naamane: None declared, Nisha Nair: None declared, Amy Anderson: None declared, Nishanthi Thalayasingam: None declared, Julie Diboll: None declared, Anne Barton Consultant of: AbbVie, Stephen Eyre: None declared, John D Isaacs Consultant of: AbbVie, Bristol-Myers Squibb, Eli Lilly, Gilead, Janssen, Merck, Pfizer, Roche, Louise Reynard: None declared, Arthur Pratt Grant/research support from: Pfizer, GlaxoSmithKlein
Collapse
|
50
|
Anderson A, Fawdon M, Booth Z, Hodgson R, Parker S, Goodfellow N, Quibell R, Bourke S. P350 Bereavement: a ‘time to remember’ event for families bereaved by cystic fibrosis. J Cyst Fibros 2020. [DOI: 10.1016/s1569-1993(20)30678-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|